Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Ankyrin repeat and SAM domain-containing protein 6 (Polycystic kidney disease protein 1) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6)

 ANKS6_RAT               Reviewed;         885 AA.
P0C0T2; Q2VWC0; Q5BJL2;
06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
14-NOV-2006, sequence version 2.
25-OCT-2017, entry version 88.
RecName: Full=Ankyrin repeat and SAM domain-containing protein 6;
AltName: Full=Polycystic kidney disease protein 1;
AltName: Full=SamCystin;
AltName: Full=Sterile alpha motif domain-containing protein 6;
Short=SAM domain-containing protein 6;
Name=Anks6; Synonyms=Pkdr1, Samd6;
Rattus norvegicus (Rat).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Rattus.
NCBI_TaxID=10116;
[1]
NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, INVOLVEMENT
IN CY, AND VARIANT CY TRP-823.
STRAIN=Brown Norway; TISSUE=Kidney;
PubMed=16207829; DOI=10.1681/ASN.2005060601;
Brown J.H., Bihoreau M.-T., Hoffmann S., Kranzlin B., Tychinskaya I.,
Obermuller N., Podlich D., Boehn S.N., Kaisaki P.J., Megel N.,
Danoy P., Copley R.R., Broxholme J., Witzgall R., Lathrop M.,
Gretz N., Gauguier D.;
"Missense mutation in sterile alpha motif of novel protein SamCystin
is associated with polycystic kidney disease in (cy/+) rat.";
J. Am. Soc. Nephrol. 16:3517-3526(2005).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=Brown Norway;
PubMed=15057822; DOI=10.1038/nature02426;
Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T.,
Smith D., Lee H.-M., Gustafson E., Cahill P., Kana A.,
Doucette-Stamm L., Weinstock K., Fechtel K., Weiss R.B., Dunn D.M.,
Green E.D., Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K.,
Zhu B., Marra M., Schein J., Bosdet I., Fjell C., Jones S.,
Krzywinski M., Mathewson C., Siddiqui A., Wye N., McPherson J.,
Zhao S., Fraser C.M., Shetty J., Shatsman S., Geer K., Chen Y.,
Abramzon S., Nierman W.C., Havlak P.H., Chen R., Durbin K.J., Egan A.,
Ren Y., Song X.-Z., Li B., Liu Y., Qin X., Cawley S., Cooney A.J.,
D'Souza L.M., Martin K., Wu J.Q., Gonzalez-Garay M.L., Jackson A.R.,
Kalafus K.J., McLeod M.P., Milosavljevic A., Virk D., Volkov A.,
Wheeler D.A., Zhang Z., Bailey J.A., Eichler E.E., Tuzun E.,
Birney E., Mongin E., Ureta-Vidal A., Woodwark C., Zdobnov E.,
Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D.,
Schmidt J., Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M.,
Abril J.F., Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O.,
Poliakov A., Huebner N., Ganten D., Goesele C., Hummel O.,
Kreitler T., Lee Y.-A., Monti J., Schulz H., Zimdahl H.,
Himmelbauer H., Lehrach H., Jacob H.J., Bromberg S.,
Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E., Lazar J.,
Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E.,
Webber C., Brandt P., Nyakatura G., Adetobi M., Chiaromonte F.,
Elnitski L., Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K.,
Miller W., Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S.,
Zhang Y., Lindpaintner K., Andrews T.D., Caccamo M., Clamp M.,
Clarke L., Curwen V., Durbin R.M., Eyras E., Searle S.M., Cooper G.M.,
Batzoglou S., Brudno M., Sidow A., Stone E.A., Payseur B.A.,
Bourque G., Lopez-Otin C., Puente X.S., Chakrabarti K., Chatterji S.,
Dewey C., Pachter L., Bray N., Yap V.B., Caspi A., Tesler G.,
Pevzner P.A., Haussler D., Roskin K.M., Baertsch R., Clawson H.,
Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J., Rosenbloom K.R.,
Trumbower H., Weirauch M., Cooper D.N., Stenson P.D., Ma B., Brent M.,
Arumugam M., Shteynberg D., Copley R.R., Taylor M.S., Riethman H.,
Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S., Mockrin S.,
Collins F.S.;
"Genome sequence of the Brown Norway rat yields insights into
mammalian evolution.";
Nature 428:493-521(2004).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 864-885.
TISSUE=Spleen;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4]
SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH BICC1, DOMAIN, AND
CHARACTERIZATION OF VARIANT CY TRP-823.
PubMed=19324013; DOI=10.1016/j.bbrc.2009.03.113;
Stagner E.E., Bouvrette D.J., Cheng J., Bryda E.C.;
"The polycystic kidney disease-related proteins Bicc1 and SamCystin
interact.";
Biochem. Biophys. Res. Commun. 383:16-21(2009).
[5]
INTERACTION WITH INVS; NEK8 AND NPHP3, DOMAIN, HYDROXYLATION AT
ASN-129, AND MUTAGENESIS OF ASN-129; ASN-209 AND GLN-433.
PubMed=23793029; DOI=10.1038/ng.2681;
Hoff S., Halbritter J., Epting D., Frank V., Nguyen T.M.,
van Reeuwijk J., Boehlke C., Schell C., Yasunaga T., Helmstadter M.,
Mergen M., Filhol E., Boldt K., Horn N., Ueffing M., Otto E.A.,
Eisenberger T., Elting M.W., van Wijk J.A., Bockenhauer D.,
Sebire N.J., Rittig S., Vyberg M., Ring T., Pohl M., Pape L.,
Neuhaus T.J., Elshakhs N.A., Koon S.J., Harris P.C., Grahammer F.,
Huber T.B., Kuehn E.W., Kramer-Zucker A., Bolz H.J., Roepman R.,
Saunier S., Walz G., Hildebrandt F., Bergmann C., Lienkamp S.S.;
"ANKS6 is a central component of a nephronophthisis module linking
NEK8 to INVS and NPHP3.";
Nat. Genet. 45:951-956(2013).
[6]
INTERACTION WITH ANKS3.
PubMed=25671767; DOI=10.1038/ki.2015.17;
Yakulov T.A., Yasunaga T., Ramachandran H., Engel C., Mueller B.,
Hoff S., Dengjel J., Lienkamp S.S., Walz G.;
"Anks3 interacts with nephronophthisis proteins and is required for
normal renal development.";
Kidney Int. 87:1191-1200(2015).
-!- FUNCTION: Required for renal function.
{ECO:0000269|PubMed:16207829}.
-!- SUBUNIT: Homooligomer (PubMed:19324013). Central component of a
complex containing at least ANKS6, INVS, NEK8 and NPHP3. ANKS6 may
organize complex assembly by linking INVS and NPHP3 to NEK8 and
INVS may target the complex to the proximal ciliary axoneme
(PubMed:23793029). Interacts (via SAM domain) with BICC1 (via KH
domains) in an RNA-dependent manner (PubMed:19324013). Interacts
with ANKS3 (PubMed:25671767). {ECO:0000269|PubMed:19324013,
ECO:0000269|PubMed:23793029, ECO:0000269|PubMed:25671767}.
-!- SUBCELLULAR LOCATION: Cell projection, cilium
{ECO:0000250|UniProtKB:Q6GQX6}. Cytoplasm
{ECO:0000269|PubMed:19324013}. Note=Localizes to the proximal
region of the primary cilium in the presence of INVS.
{ECO:0000250|UniProtKB:Q6GQX6}.
-!- TISSUE SPECIFICITY: Widely expressed with moderate level in brain,
skeletal muscle and testis. Expressed in renal tubules.
{ECO:0000269|PubMed:16207829}.
-!- DOMAIN: The ankyrin repeats are necessary and sufficient for NEK8-
binding. {ECO:0000269|PubMed:23793029}.
-!- DOMAIN: The SAM domain mediates interaction with the SAM domain of
ANKS3. {ECO:0000269|PubMed:19324013}.
-!- PTM: Hydroxylated at Asn-129, most probably by HIF1AN. This
hydroxylation results in decreased NEK8-binding.
{ECO:0000269|PubMed:23793029}.
-!- DISEASE: Note=Defects in Anks6 are the cause of polycystic kidney
disease (cy). Heterozygous cy rats are characterized by
progressive formation and enlargement of cysts in kidneys.
{ECO:0000269|PubMed:16207829, ECO:0000269|PubMed:19324013}.
-!- SEQUENCE CAUTION:
Sequence=AAH91436.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AY661303; AAT76432.1; -; mRNA.
EMBL; AABR03040311; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC091436; AAH91436.1; ALT_SEQ; mRNA.
RefSeq; NP_001015028.2; NM_001015028.2.
UniGene; Rn.101322; -.
ProteinModelPortal; P0C0T2; -.
SMR; P0C0T2; -.
CORUM; P0C0T2; -.
STRING; 10116.ENSRNOP00000056754; -.
PaxDb; P0C0T2; -.
PRIDE; P0C0T2; -.
GeneID; 362515; -.
KEGG; rno:362515; -.
UCSC; RGD:3334; rat.
CTD; 203286; -.
RGD; 3334; Anks6.
eggNOG; KOG4369; Eukaryota.
eggNOG; KOG4374; Eukaryota.
eggNOG; COG0666; LUCA.
HOGENOM; HOG000231711; -.
HOVERGEN; HBG059049; -.
InParanoid; P0C0T2; -.
KO; K21415; -.
PhylomeDB; P0C0T2; -.
TreeFam; TF328552; -.
PRO; PR:P0C0T2; -.
Proteomes; UP000002494; Unplaced.
GO; GO:0005929; C:cilium; IEA:UniProtKB-SubCell.
GO; GO:0005737; C:cytoplasm; IDA:RGD.
GO; GO:0042803; F:protein homodimerization activity; IDA:RGD.
CDD; cd00204; ANK; 3.
Gene3D; 1.25.40.20; -; 4.
InterPro; IPR002110; Ankyrin_rpt.
InterPro; IPR020683; Ankyrin_rpt-contain_dom.
InterPro; IPR036770; Ankyrin_rpt-contain_sf.
InterPro; IPR001660; SAM.
InterPro; IPR013761; SAM/pointed.
Pfam; PF12796; Ank_2; 3.
Pfam; PF00536; SAM_1; 1.
PRINTS; PR01415; ANKYRIN.
SMART; SM00248; ANK; 10.
SMART; SM00454; SAM; 1.
SUPFAM; SSF47769; SSF47769; 1.
SUPFAM; SSF48403; SSF48403; 2.
PROSITE; PS50297; ANK_REP_REGION; 1.
PROSITE; PS50088; ANK_REPEAT; 7.
PROSITE; PS50105; SAM_DOMAIN; 1.
1: Evidence at protein level;
ANK repeat; Cell projection; Cilium; Complete proteome; Cytoplasm;
Disease mutation; Hydroxylation; Phosphoprotein; Reference proteome;
Repeat.
CHAIN 1 885 Ankyrin repeat and SAM domain-containing
protein 6.
/FTId=PRO_0000067067.
REPEAT 8 37 ANK 1.
REPEAT 68 97 ANK 2.
REPEAT 101 130 ANK 3.
REPEAT 134 163 ANK 4.
REPEAT 181 210 ANK 5.
REPEAT 215 244 ANK 6.
REPEAT 282 312 ANK 7.
REPEAT 316 345 ANK 8.
REPEAT 350 379 ANK 9.
REPEAT 383 414 ANK 10.
DOMAIN 773 836 SAM. {ECO:0000255|PROSITE-
ProRule:PRU00184}.
COMPBIAS 609 769 Ser-rich.
MOD_RES 129 129 3-hydroxyasparagine.
{ECO:0000269|PubMed:23793029}.
MOD_RES 650 650 Phosphoserine.
{ECO:0000250|UniProtKB:Q68DC2}.
MOD_RES 734 734 Phosphoserine.
{ECO:0000250|UniProtKB:Q68DC2}.
MOD_RES 742 742 Phosphoserine.
{ECO:0000250|UniProtKB:Q68DC2}.
VARIANT 823 823 R -> W (in cy; loss of ability to self-
associate, does not affect interaction
with Bicc1).
{ECO:0000269|PubMed:16207829,
ECO:0000269|PubMed:19324013}.
MUTAGEN 129 129 N->A: Decreased NEK8-binding, but no
effect on INVS-binding; when associated
with A-209.
{ECO:0000269|PubMed:23793029}.
MUTAGEN 209 209 N->A: Decreased NEK8-binding, but no
effect on INVS-binding; when associated
with A-129.
{ECO:0000269|PubMed:23793029}.
MUTAGEN 433 433 Q->R: No effect on interaction with INVS,
NEK8 AND NPHP3, nor on ciliary
localization. Unable to rescue ANKS6
knockout in a heterologous system.
{ECO:0000269|PubMed:23793029}.
CONFLICT 870 870 C -> S (in Ref. 1; AAT76432 and 3;
AAH91436). {ECO:0000305}.
SEQUENCE 885 AA; 93809 MW; B4F91C5DFCD2D35E CRC64;
MGEGALAPGL QLLLRACEQG DTDTARRLLE PGGEPVAGSE AGAEPAGPEA ARAVEAGTPV
PVDCSDEAGN SALQLAAAGG HEPLVRFLLR RGASVNSRNH YGWSALMQAA RCGHASVAHL
LLDHGADVNA QNRLGASVLT VASRGGHLGV VKLLLEAGAT VDHRNPSGES TASGGSRDEL
LGITALMAAV QHGHEAVVRL LMEWGADPNH TARTVGWSPL MLAALLGKLS VVQQLVEKGA
NPDHLGVLEK TAFEVALDRK HRDLADYLDP LTTVRPKTDE EKRRPDIFHA LKMGNFQLVK
EIADEDPNHV NLVNGDGATP LMLAAVTGQL PLVQLLVEKH ADMNKQDSVH GWTALMQATY
HGNKEIVKYL LNQGADVTLR AKNGYTAFDL VMLLNDPDTE LVRLLASVCM QVNKDRGGRP
SHRPPLPHSK ARQPWSIPML PDDKGGLKSW WSRMSNRFRK LKLMQTLPRG LAANQPLPFS
DEPELALDST MRAPPQDRTN HLGPPEAAHA AKDSGPGNPR REKDDVLLTT MLRNGAPFPR
LPSDKLKAVI PPFLPPSSFE LWSSDRSRTC PNGKADPMKT VLPPRASRAH PVGCVGTDGA
AGRPVKFPSI SRSPTSPASS GNFNHSPHSS GGASGVGSMS RLGGELHNRS GGSVDSVLSQ
IAAQRKKAAG LCEQKPPCQQ SSPVGPATGS SPPELPASLL GSGSGSSNVT SSSKKLDPGK
RPPSGTSATS KSTSPTLTPS PSPKGHTAES SVSSSSSHRQ SKSSGGSSSG TITDEDELTG
ILKKLSLEKY QPIFEEQEVD MEAFLTLTDG DLQELGIKTD GSRQQILAAI SELNAGKGRE
RQILQETIHN FHSSFESSAS NTRAPGNSPC MAGWVRPEET VSSRR


Related products :

Catalog number Product name Quantity
EIAAB37300 Homo sapiens,Human,KIAA0524,SAM domain-containing protein 2,SAMD2,SARM,SARM1,Sterile alpha and Armadillo repeat protein,Sterile alpha and TIR motif-containing protein 1,Sterile alpha motif domain-cont
EIAAB37228 Major retinal SAM domain-containing protein,Mouse,Mr-s,Mus musculus,SAM domain-containing protein 11,Samd11,Sterile alpha motif domain-containing protein 11
CSB-EL001805RA Rat Ankyrin repeat and sterile alpha motif domain-containing protein 1B(ANKS1B) ELISA kit 96T
ANS1B_MOUSE Mouse ELISA Kit FOR Ankyrin repeat and sterile alpha motif domain-containing protein 1B 96T
CSB-EL001805RA Rat Ankyrin repeat and sterile alpha motif domain-containing protein 1B(ANKS1B) ELISA kit SpeciesRat 96T
CSB-EL001805MO Mouse Ankyrin repeat and sterile alpha motif domain-containing protein 1B(ANKS1B) ELISA kit 96T
CSB-EL001805HU Human Ankyrin repeat and sterile alpha motif domain-containing protein 1B(ANKS1B) ELISA kit 96T
CSB-EL001805MO Mouse Ankyrin repeat and sterile alpha motif domain-containing protein 1B(ANKS1B) ELISA kit SpeciesMouse 96T
CSB-EL001805HU Human Ankyrin repeat and sterile alpha motif domain-containing protein 1B(ANKS1B) ELISA kit SpeciesHuman 96T
EIAAB37254 Homo sapiens,Human,SAM domain-containing protein 8,SAMD8,SMSr,Sphingomyelin synthase-related protein 1,Sterile alpha motif domain-containing protein 8
EIAAB37245 Atherin,Oryctolagus cuniculus,Rabbit,SAM domain-containing protein 1,SAMD1,Sterile alpha motif domain-containing protein 1
EIAAB37246 Atherin,Homo sapiens,Human,SAM domain-containing protein 1,SAMD1,Sterile alpha motif domain-containing protein 1
EIAAB37249 Homo sapiens,Human,SAM domain-containing protein 5,SAMD5,SAMDC1,Sterile alpha motif domain-containing protein 5
EIAAB37231 Homo sapiens,HSD42,HSD-42,Human,SAM domain-containing protein 13,SAMD13,Sterile alpha motif domain-containing protein 13
EIAAB37225 C20orf136,Homo sapiens,Human,SAM domain-containing protein 10,SAMD10,Sterile alpha motif domain-containing protein 10
EIAAB37235 C14orf174,FAM15A,Homo sapiens,Human,SAM domain-containing protein 15,SAMD15,Sterile alpha motif domain-containing protein 15
EIAAB37253 Homo sapiens,Human,SAM domain-containing protein 7,SAMD7,Sterile alpha motif domain-containing protein 7
EIAAB37247 Homo sapiens,Human,SAM domain-containing protein 3,SAMD3,Sterile alpha motif domain-containing protein 3
EIAAB37229 Homo sapiens,Human,SAM domain-containing protein 12,SAMD12,Sterile alpha motif domain-containing protein 12
EIAAB37240 Kiaa2005,Mouse,Mus musculus,SAM domain-containing protein 9-like,Samd9l,Sterile alpha motif domain-containing protein 9-like
EIAAB37248 Gm623,Mouse,Mus musculus,SAM domain-containing protein 3,Samd3,Sterile alpha motif domain-containing protein 3
EIAAB37234 Homo sapiens,Human,SAM domain-containing protein 14,SAMD14,Sterile alpha motif domain-containing protein 14
EIAAB37227 Homo sapiens,Human,SAM domain-containing protein 11,SAMD11,Sterile alpha motif domain-containing protein 11
EIAAB37241 C7orf6,DRIF2,Homo sapiens,Human,KIAA2005,SAM domain-containing protein 9-like,SAMD9L,Sterile alpha motif domain-containing protein 9-like,UEF
EIAAB37233 Rat,Rattus norvegicus,SAM domain-containing protein 14,Samd14,Sterile alpha motif domain-containing protein 14


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur